FDA approves Phase II trial for obesity-treating drug pemvidutide
The Food and Drug Administration (FDA) has approved a Phase II clinical trial for investigational obesity-treating drug pemvidutide. The...
top of page
Browse by category
Search
Dasiglucagon effective in preventing post-gastric bypass hypoglycaemia
Post-op hypoglycaemia - Single mini-doses of dasiglucagon effectively reduced time spent in hypoglycaemia after meals in individuals who...
Browse by tag
bottom of page